Skip to content

Clinical trial Retterspitz cream in patients with various manifestations of injuries of the muscular, tendon and joint system

Clinical trial Retterspitz cream in patients with various manifestations of injuries of the muscular, tendon and joint system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00019006
Enrollment
96
Registered
2019-10-24
Start date
2019-11-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various manifestations of injuries of the muscular, tendon and joint system

Interventions

Group 1: Retterspitz muscle cream Group 2: Placebo

Sponsors

Retterspitz GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Included are patients with acute blunt injuries of the muscular, tendon and joint system, which are not permanently subject to therapy. The trauma must not be older than 48 hours. The presence of at least one of the following types of injury must be ensured: - bruise - Strain - tension - swelling - Sprain - hematoma Before being included in the study, the investigator will ensure that there is no serious traumatic or chronic finding and that long-term treatment is not required

Exclusion criteria

Exclusion criteria: - Patients with an open wound on the affected part of the body - Patients with fractures, torn ligaments, surgical procedures, with recurrent chronic complaints and local skin infections, which do not allow the study medication. - Patients taking anticoagulation or anti-platelet drugs - Age 85 - Allergy or intolerance to one or more of the ingredients used - permanent use of painkillers - Use of steroidal or non-steroidal anti-inflammatory drugs within 48 hours of the onset of injury (topically, orally or intravenously) - Pregnancy and breast feeding period - Inability to adequately participate in the study

Design outcomes

Primary

MeasureTime frame
Symptom "pain" with bruising, straining, tension, swelling, sprain and hematoma"; pain grading from 0 (no pain) to 10 (strongest imaginable pain). Reduction in the severity of the complaint over the period of use.

Secondary

MeasureTime frame
Side effects related to the application

Countries

Germany

Contacts

Public ContactNicole Schuster

Retterspitz GmbH

dr.schuster@retterspitz.de+49 911 / 50700-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026